Skip to main content

Medications for Follicular Lymphoma

Follicular lymphoma is a type of non-Hodgkins lymphoma that develops from a B cell lymphocyte (a specific type of white blood cell) which starts to grow and divide in abnormal or uncontrolled way.  Follicular lymphoma is an indolent lymphoma which means that it is a slow growing and slow spreading lymphoma.


Some Follicular lymphomas can undergo change and can become a transformed follicular lymphoma that has different properties than the original lymphoma and may require different treatments.

Drugs used to treat Follicular Lymphoma

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Rituxan 10 1 review for Rituxan to treat Follicular Lymphoma
Rx C N
Generic name:
rituximab systemic
Drug class:
antirheumatics, CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
rituximab 9.3 4 reviews for rituximab to treat Follicular Lymphoma
Rx C N
Generic name:
rituximab systemic
Brand names:
Rituxan, Truxima, Ruxience, Riabni
Drug class:
antirheumatics, CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Kymriah Rate Add review
Rx N
Generic name:
tisagenlecleucel systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Revlimid 6.0 1 review for Revlimid to treat Follicular Lymphoma
Rx X N
Generic name:
lenalidomide systemic
Drug class:
miscellaneous antineoplastics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
lenalidomide 6.0 1 review for lenalidomide to treat Follicular Lymphoma
Rx X N
Generic name:
lenalidomide systemic
Brand name:
Revlimid
Drug class:
miscellaneous antineoplastics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Truxima Rate Add review
Rx C N
Generic name:
rituximab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tazverik 9.0 1 review for Tazverik to treat Follicular Lymphoma
Rx N
Generic name:
tazemetostat systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Yescarta Rate Add review
Rx N
Generic name:
axicabtagene ciloleucel systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Lunsumio 8.0 1 review for Lunsumio to treat Follicular Lymphoma
Rx N
Generic name:
mosunetuzumab systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Brukinsa Rate Add review
Rx N
Generic name:
zanubrutinib systemic
Drug class:
BTK inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
zanubrutinib Rate Add review
Rx N
Generic name:
zanubrutinib systemic
Brand name:
Brukinsa
Drug class:
BTK inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
idelalisib 4.5 2 reviews for idelalisib to treat Follicular Lymphoma
Rx D N X
Generic name:
idelalisib systemic
Brand name:
Zydelig
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Gazyva Rate Add review
Rx C N
Generic name:
obinutuzumab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zydelig 4.5 2 reviews for Zydelig to treat Follicular Lymphoma
Rx D N X
Generic name:
idelalisib systemic
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
clarithromycin Off-label 5.0 1 review for clarithromycin to treat Follicular Lymphoma
Rx C N
Generic name:
clarithromycin systemic
Drug class:
macrolides
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
obinutuzumab 9.5 2 reviews for obinutuzumab to treat Follicular Lymphoma
Rx C N
Generic name:
obinutuzumab systemic
Brand name:
Gazyva
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Intron A Rate Add review
Rx C N
Generic name:
interferon alfa-2b systemic
Drug class:
antineoplastic interferons
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Rituxan Hycela Rate Add review
Rx N
Generic name:
hyaluronidase / rituximab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
duvelisib Off-label Rate Add review
Rx N
Generic name:
duvelisib systemic
Drug class:
PI3K inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
interferon alfa-2b Rate Add review
Rx C N
Generic name:
interferon alfa-2b systemic
Brand name:
Intron A
Drug class:
antineoplastic interferons
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
tazemetostat 9.0 1 review for tazemetostat to treat Follicular Lymphoma
Rx N
Generic name:
tazemetostat systemic
Brand name:
Tazverik
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Ruxience Rate Add review
Rx C N
Generic name:
rituximab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
hyaluronidase / rituximab Rate Add review
Rx N
Generic name:
hyaluronidase / rituximab systemic
Brand name:
Rituxan Hycela
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
Riabni Rate Add review
Rx C N
Generic name:
rituximab systemic
Drug class:
CD20 monoclonal antibodies
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
axicabtagene ciloleucel Rate Add review
Rx N
Generic name:
axicabtagene ciloleucel systemic
Brand name:
Yescarta
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph

Frequently asked questions

View more FAQ

Learn more about Follicular Lymphoma

Care guides

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.